These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13024867)

  • 1. [Theoretical bases and experimental studies with human antireticulo-endothelial serum in vitro on the phenomenon of lupus erythematosus in normal subject; considerations on erythematoid disease as a disease of auto-antibodies].
    CAPPELLI E
    Minerva Dermatol; 1952 Oct; 27(10):215-20. PubMed ID: 13024867
    [No Abstract]   [Full Text] [Related]  

  • 2. [Theoretical bases and experimental production in vitro of so-called lupus erythematosus phenomenon, L. E. phenomenon, in blood of normal subjects].
    CAPPELLI E
    Accad Medica; 1953 May; 68(5):131-2. PubMed ID: 13103988
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
    Yuan M; Tan Y; Pang Y; Li YZ; Song Y; Yu F; Zhao MH
    Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interleukin 10 in disseminated lupus erythematosus].
    Emilie D
    J Soc Biol; 2002; 196(1):19-21. PubMed ID: 12134628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Remarks on Kaposi-Irgang's deep lupus erythematosus and on erythematoid anetoderma].
    RYLL-NARDZEWSKI C; KUDEJKO T; KUDEJKO J
    Ann Dermatol Syphiligr (Paris); 1960; 87():627-36. PubMed ID: 13745054
    [No Abstract]   [Full Text] [Related]  

  • 6. [Production of so-called L.E. phenomenon in vitro with blood serum taken from acute disseminated lupus erythematosus].
    MARMONT A; FUSCO F
    Accad Medica; 1952 Feb; 67(2):57-62. PubMed ID: 12975925
    [No Abstract]   [Full Text] [Related]  

  • 7. The Relationship Between Systemic Lupus Erythematosus Activity and Persistent Positive Antiphospholipid Antibodies.
    Sarabi ZS; Sahebari M; Rezaie AE; Norouzi MT; Hashemzadeh K; Mirfeizi Z
    Curr Rheumatol Rev; 2018; 14(2):145-152. PubMed ID: 27881058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
    Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
    Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of systemic lupus erythematosus in hypothyroid patients: two case reports and mini review.
    Bakr A; Laimon W; El-Ziny MA; Hammad A; El-Hawary AK; Elsharkawy AA; El-Refaey AM; Salem NA; El-Mougy A; Zedan MM; Aboelenin HM; Eid R; Sarhan A
    Lupus; 2014 Jul; 23(8):825-8. PubMed ID: 24569395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preliminary data on the phenomenon of auto-erythrophagocytosis in vitro; mechanism of formation and interpretation of so-called L E cell].
    CAPPELLI E
    Accad Medica; 1952 Mar; 67(3):159-60. PubMed ID: 12975936
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of biologicals for the therapy of lupus erythematosus.
    Neumann D; Tschernig T; Boraschi D
    Expert Rev Vaccines; 2007 Dec; 6(6):1001-11. PubMed ID: 18034656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial childhood systemic lupus erythematosus: report of 2 cases.
    Roy AK; Pal D; Das S; Kar C; Maiti A
    J Indian Med Assoc; 2007 Mar; 105(3):141, 148. PubMed ID: 17824469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.
    Tan EM; Schur PH; Carr RI; Kunkel HG
    J Clin Invest; 1966 Nov; 45(11):1732-40. PubMed ID: 4959277
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
    İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
    Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The phenomenon of autoerythrophagocytosis in vitro; comparison with formative mechanism and attempt to interpret the so-called lupus erythematosus cells].
    CAPPELLI E
    Minerva Dermatol; 1952 May; 27(5):108-14. PubMed ID: 12982584
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence and factors associated with headache in patients with systemic lupus erythematosus.
    Weder-Cisneros ND; Téllez-Zenteno JF; Cardiel MH; Guibert-Toledano M; Cabiedes J; Velásquez-Paz AL; García-Ramos G; Cantú C
    Cephalalgia; 2004 Dec; 24(12):1031-44. PubMed ID: 15566417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis.
    Maloney KC; Ferguson TS; Stewart HD; Myers AA; De Ceulaer K
    Lupus; 2017 Nov; 26(13):1448-1456. PubMed ID: 28480787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to histones in systemic lupus erythematosus.
    Fishbein E; Alarcon-Segovia D; Vega JM
    Clin Exp Immunol; 1979 Apr; 36(1):145-50. PubMed ID: 380854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of biological treatments on the anti-dsDNA and anti-nucleosome tests.
    Infantino M; Grossi V; Benucci M; Li Gobbi F; Damiani A; Manfredi M
    Lupus; 2018 Jan; 27(1):40-48. PubMed ID: 28587585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.